Fig. 3From: The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 aloneCognitive progression in patients with mild cognitive impairment according to their amyloid profile. A Kaplan-Meier curve and B age- and sex-adjusted Cox regression display the risk of cognitive progression of all four amyloid profiles (outcome defined as MMSE < 24)Back to article page